Emily Gosselin
Director, CMC Corner Therapeutics
Emily Gosselin is a Senior Scientist at Corner Therapeutics. She leads a team of researchers who work to design and optimize formulations that enable the delivery of immunotherapies. She received her Ph.D. in Bioengineering from the University of Maryland under Dr. Christopher Jewell.
Seminars
Wednesday 3rd June 2026
A T-Cell Selective LNP to Deliver STING Agonists to Eliminate Autoimmune T-Cells
4:45 pm
- RNA-based therapy that controls the cGAS-STING pathway in vivo
- cGAS-STING pathway activation in T-cells to create an intracellular factory of apoptosis-inducing signals
- Delivery of mRNA to activated T-cells mediated by targeting moieties on LNPs
